Arcticzymes Technologies (AZT.OL)

Arcticzymes Technologies stock price today, ATLAS forecast and fair value

Healthcare · Biotechnology · Oslo Børs · Norway

NOK 21.00▲ +2.44%

Prices as of Oct 27, 2026 · NOK

ATLAS fair value

NOK 9.36

Above fair value · 124% premium

Chance of rising in 1 month

49%

that it ends higher than today in 21 sessions

0%coin flip 50%100%

This is just the summary. See everything on Arcticzymes Technologies in ATLAS

ATLAS's own quantitative analysis, all in one place.

  • Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
  • Officers and shareholdersWho runs the company and which funds hold its shares.
  • Customer and supplier mapWho it does business with, from its own filings.
  • ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
  • AlertsWe let you know when something changes in your stocks.
See everything included
  • Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
  • NewsThe latest on the company, in one place.
  • Crisis simulatorHow your portfolio would do in a crash like 2008.
  • Practice risk-free$10,000 in virtual money to invest at real prices.
  • Global screenerSearch US stocks and stocks from 47 countries with filters.

On Arcticzymes Technologies

  • Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
  • Officers and shareholdersWho runs the company and which funds hold its shares.
  • Customer and supplier mapWho it does business with, from its own filings.
  • Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
  • NewsThe latest on the company, in one place.

And for you

  • ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
  • AlertsWe let you know when something changes in your stocks.
  • Crisis simulatorHow your portfolio would do in a crash like 2008.
  • Practice risk-free$10,000 in virtual money to invest at real prices.
  • Global screenerSearch US stocks and stocks from 47 countries with filters.
Get started →

Plans from €3.99 a month.

ATLAS estimates Arcticzymes Technologies's fair value at about NOK 9.36 per share (reasonable range: NOK 7.04 to NOK 13.21). At NOK 21.00, the stock trades 124% above it.

It is calculated with a blend of a discounted cash-flow model and peer valuation multiples. Confidence in the estimate is medium. It is an estimate, not a promise: if the company's results change, so does its fair value.

ATLAS's model gives Arcticzymes Technologies a 49% chance of finishing higher a month from now (21 trading sessions) than today: close to a coin flip.

In half of the simulated outcomes the price ends between NOK 19.46 and NOK 22.58; in 9 out of 10, between NOK 17.06 and NOK 25.75. Estimated annual volatility is 39%.

Price, last 12 months (weekly close)

Arcticzymes Technologies (AZT.OL) — Price, last 12 months (weekly close)Oct 24, 2025: NOK 30.00. Oct 27, 2026: NOK 21.00. ▼NOK 30.00NOK 18.85Oct 24, 2025Oct 27, 2026

Key numbers

Market cap
NOK 959M
Market cap (USD)
$103M
P/E ratio
67.3
52-week high
NOK 29.50
52-week low
NOK 18.30
Revenue (12 months)
NOK 133M
Gross margin
95.4%
Operating margin
15.2%
Net margin
11.5%
Beta
0.57

What this means

These are two different questions: fair value looks at the business (what it is worth given what it earns) and the odds look at the price over the next month. Arcticzymes Technologies sits above fair value and its odds of rising over a month are close to a coin flip. An expensive stock can keep climbing and a cheap one can keep falling, which is why ATLAS shows the two readings separately.

Over the last 52 weeks AZT.OL has traded between NOK 18.30 and NOK 29.50. Today it is 28.8% below that high and 15% above its low.

On the business: net margin is 11.5%; it trades at 67.3 times earnings.

Its beta is 0.57: it tends to move less than the market.

About the company

ArcticZymes Technologies ASA, a life sciences company, develops, manufactures, and commercializes recombinant enzymes for use in molecular research, in vitro diagnostics, and biomanufacturing.

Want to see everything about Arcticzymes Technologies?

Get started →

Plans from €3.99 a month.

Comparable companies

Other companies in the same line of business:

Frequently asked questions

What is Arcticzymes Technologies (AZT.OL) fair value?

About NOK 9.36 per share according to ATLAS (reasonable range: NOK 7.04 to NOK 13.21). With the stock at NOK 21.00, it is 124% above it.

What is the chance AZT.OL goes up next month?

49%: close to a coin flip. In half of the simulated outcomes, AZT.OL ends the month between NOK 19.46 and NOK 22.58.

How big is Arcticzymes Technologies and what is its P/E ratio?

Arcticzymes Technologies's market capitalization is NOK 959M. Its price-to-earnings (P/E) ratio is 67.3: you pay NOK 67.3 for each NOK 1.00 of yearly earnings.

How volatile is AZT.OL?

ATLAS estimates annual volatility at 39%. In a typical month, half of the outcomes end between NOK 19.46 and NOK 22.58.

Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer

ATLAS Signals

ATLAS Signals, every week

The week in the market, three stocks on ATLAS’s radar and what comes next. Get it every Monday.

By subscribing you agree to receive ATLAS Signals by email every Monday. You can unsubscribe with one click at any time. Privacy